5300012025-07-012025-09-305300012025-09-305300012025-03-315300012025-04-012025-09-305300012025-07-012025-09-30in-capmkt:OtherExpenses1Member5300012025-07-012025-09-30in-capmkt:OtherExpenses2Member5300012025-04-012025-09-30in-capmkt:OtherExpenses1Member5300012025-04-012025-09-30in-capmkt:OtherExpenses2Member5300012025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15300012025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25300012025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15300012025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares530001GUJALKALINOTLISTEDINE186A01019GUJARAT ALKALIES AND CHEMICALS LIMITEDMain BoardEquity2025-04-012026-03-312025-11-072025-10-27INRLakhsQuarterlySecond quarterSingle segmentCHEMICALS2025-11-0713:00:002025-11-0715:40:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated108319000005929000001142480000043309000000-2950000011029000001577000001039400000468860000011290000000134800000013480000022700000-50700000-280000000162800000000600000163400000-1890800000-1727400000734400000102.232.23002.232.231 The above financial results have been prepared in accordance with the Indian Accounting Standards (Ind AS) specified under Section 133 of the Companies Act 2013 read with relevant rules. <BR> 2 The above results have been reviewed by the Audit Committee of Directors and approved by the Board of Directors of the Company at their meetings held on 7th November 2025. <BR> 3 In accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the Statutory Auditors have carried out a limited review of the consolidated financial results for the quarter and six months ended 30th September 2025. <BR> 4 The Companys operations fall under single segment namely Chemicals as per Ind AS 108 Segment Reporting. <BR> 5 The Board of Directors of the Company declared Dividend of Rs.15.80 per share on 73436928 Equity Shares of Rs.10 each, amounting to Rs.11603.03 lakhs for the financial year ended 31st March 2025 and the same were approved by the Shareholders at the Annual General Meeting held on 26th September 2025. <BR> 6 Employee Benefits Expense for the quarter and six months ended 30th September 2025 includes Rs.3784.43 lakhs and Rs.5284.43 lakhs respectively towards pay revision of employees. <BR> 7 During the quarter ended 30th September 2025 the Company has made provisions of Rs 1549.24 lakhs for the goods damaged due to the fire at Sanghvi Organics Pvt. Ltd.(contract manufacturer for Company) Ankleshwar, Gujarat. <BR> 8 The Consolidated Financial Results includes result of 60% equity Joint Venture company - GACL-NALCO Alkalies & Chemicals Pvt. Ltd. (Material Subsidiary as per SEBI [Listing Obligations Disclosure Requirements] Regulations, 2015). <BR> <BR> 2025-04-012025-09-30UnauditedConsolidated21883100000677600000225607000008509200000018360000019909000002944000002058100000929420000022330400000230300000023030000039100000-49500000-104000000240700000000-21510000025600000142800000168400000734400000100.350.35000.350.35Power, fuel & other Utilities3067000000Other Expenses1621600000Power, fuel & other Utilities6026300000Other Expenses32679000004520870000037100000000810000000282300000017424900000017300000135030000018792500000067320000067876500000453680000019320000029462000002509300000120990000012100000516100000738680000010576000001237100000142183000000082094800000734400000549695000005570390000055703900000256970000000026224000005192100000213080000065467000000013869600000371320000031060000055500000005860600000173530000011309100000874100000237800000100300000012521300000002639090000082094800000294400000323600000-2848000000-228200000300000-2750000015420000007798000000-6200000020580000000-100000016300000-1370000000-13000000309000000484000000-4400000-215100000002760000000305820000032885000000009070000003197800000-2151000000300000000004000001377400000000000000000000001407000005460000000-13965000000000000030329000003515700000111000008000001826000000117600000-55970000012416000005500000124710000012622000002509300000Fair Value of Equity Instruments - FVTOCI-1961400000Remeasurement of Defined Benefit Gratuity-331300000-2292700000Fair Value of Equity Instruments - FVTOCI439500000Remeasurement of Defined Benefit Gratuity-35670000082800000-401900000-6000000000-1890800000142800000